These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 1459003

  • 1. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
    Zätterström UK, Johansson M, Källén A, Baldetorp B, Oredsson S, Wennerberg J, Killander D.
    Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
    [Abstract] [Full Text] [Related]

  • 2. Cell cycle time, growth fraction and cell loss in xenografted head and neck cancer.
    Zätterström UK, Källén A, Wennerberg J.
    In Vivo; 1991; 5(2):137-42. PubMed ID: 1768782
    [Abstract] [Full Text] [Related]

  • 3. A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
    Eidukevicius R, Characiejus D, Janavicius R, Kazlauskaite N, Pasukoniene V, Mauricas M, Den Otter W.
    BMC Cancer; 2005 Sep 22; 5():122. PubMed ID: 16176590
    [Abstract] [Full Text] [Related]

  • 4. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
    Fogt F, Wan J, O'Hara C, Bistrian BR, Blackburn GL, Istfan NW.
    Cytometry; 1991 Sep 22; 12(1):33-41. PubMed ID: 1825629
    [Abstract] [Full Text] [Related]

  • 5. Cell kinetics in mouse epidermis studied by bivariate DNA/bromodeoxyuridine and DNA/keratin flow cytometry.
    Kirkhus B, Clausen OP.
    Cytometry; 1990 Sep 22; 11(2):253-60. PubMed ID: 1690627
    [Abstract] [Full Text] [Related]

  • 6. Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.
    Bertuzzi A, Faretta M, Gandolfi A, Sinisgalli C, Starace G, Valoti G, Ubezio P.
    Bull Math Biol; 2002 Mar 22; 64(2):355-84. PubMed ID: 11926121
    [Abstract] [Full Text] [Related]

  • 7. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
    Riccardi A, Danova M, Wilson G, Ucci G, Dörmer P, Mazzini G, Brugnatelli S, Girino M, McNally NJ, Ascari E.
    Cancer Res; 1988 Nov 01; 48(21):6238-45. PubMed ID: 3167869
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneous cell kinetics in tumors analyzed with a simulation model for bromodeoxyuridine single and multiple labeling.
    Baisch H, Otto U, Hatje U, Fack H.
    Cytometry; 1995 Sep 01; 21(1):52-61. PubMed ID: 8529471
    [Abstract] [Full Text] [Related]

  • 9. Cell proliferation kinetics in human tumor xenografts measured with iododeoxyuridine labeling and flow cytometry: a study of heterogeneity and a comparison between different methods of calculation and other proliferation measurements.
    Perez LA, Dombkowski D, Efird J, Preffer F, Suit HD.
    Cancer Res; 1995 Jan 15; 55(2):392-8. PubMed ID: 7812972
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
    Wilson GD, McNally NJ, Dunphy E, Kärcher H, Pfragner R.
    Cytometry; 1985 Nov 15; 6(6):641-7. PubMed ID: 4064843
    [Abstract] [Full Text] [Related]

  • 12. Double labeling autoradiography. Cell kinetic studies with 3H- and 14C-thymidine.
    Schultze B.
    J Histochem Cytochem; 1981 Jan 15; 29(1A Suppl):109-16. PubMed ID: 7288149
    [Abstract] [Full Text] [Related]

  • 13. Estimation of the dividing fraction and potential doubling time of tumors using cytochalasin B.
    Shibamoto Y, Streffer C.
    Cancer Res; 1991 Oct 01; 51(19):5134-8. PubMed ID: 1913638
    [Abstract] [Full Text] [Related]

  • 14. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.
    Lawrence TS, Davis MA, Maybaum J, Mukhopadhyay SK, Stetson PL, Normolle DP, McKeever PE, Ensminger WD.
    Cancer Res; 1992 Jul 01; 52(13):3698-704. PubMed ID: 1617642
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cell proliferation kinetics of six xenografted human cervix carcinomas: comparison of autoradiography and bromodeoxyuridine labelling methods.
    van Oostrum IE, Rozemuller E, Knol RF, Erkens-Schulze S, Rutgers DH.
    Cell Tissue Kinet; 1990 Nov 01; 23(6):523-44. PubMed ID: 2276171
    [Abstract] [Full Text] [Related]

  • 17. Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.
    Schultz-Hector S, Begg AC, Hofland I, Kummermehr J, Sund M.
    Br J Cancer; 1993 Dec 01; 68(6):1097-103. PubMed ID: 8260360
    [Abstract] [Full Text] [Related]

  • 18. The percentage labelled mitoses technique shows the mean cell cycle time to be half its true value in Carcinoma NT. I. [3H]thymidine and vincristine studies.
    Hamilton E, Dobbin J.
    Cell Tissue Kinet; 1983 Sep 01; 16(5):473-81. PubMed ID: 6883431
    [Abstract] [Full Text] [Related]

  • 19. Kinetics of bromodeoxyuridine elimination from human colon cancer cells in vitro and in vivo.
    Lawrence TS, Davis MA, Stetson PL, Maybaum J, Ensminger WD.
    Cancer Res; 1994 Jun 01; 54(11):2964-8. PubMed ID: 8187082
    [Abstract] [Full Text] [Related]

  • 20. BrdUrd incorporation studies for evaluation of spermatogenesis in the blue fox.
    Clausen OP, Berg KA, Kirkhus B, De Angelis P, Huitfeldt H.
    Cytometry; 1992 Jun 01; 13(4):374-80. PubMed ID: 1526196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.